Akero Therapeutics Inc (AKRO)
32.04
-0.30
(-0.91%)
USD |
NASDAQ |
Nov 04, 16:00
32.04
0.00 (0.00%)
After-Hours: 20:00
Akero Therapeutics Total Assets (Quarterly): 865.04M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 865.04M |
| March 31, 2024 | 912.24M |
| December 31, 2023 | 580.27M |
| September 30, 2023 | 635.33M |
| June 30, 2023 | 663.81M |
| March 31, 2023 | 348.82M |
| December 31, 2022 | 356.57M |
| September 30, 2022 | 379.41M |
| June 30, 2022 | 185.68M |
| March 31, 2022 | 169.89M |
| December 31, 2021 | 195.55M |
| September 30, 2021 | 223.53M |
| Date | Value |
|---|---|
| June 30, 2021 | 238.01M |
| March 31, 2021 | 257.62M |
| December 31, 2020 | 273.34M |
| September 30, 2020 | 300.04M |
| June 30, 2020 | 114.06M |
| March 31, 2020 | 126.62M |
| December 31, 2019 | 138.12M |
| September 30, 2019 | 150.14M |
| June 30, 2019 | 163.17M |
| March 31, 2019 | 72.07M |
| December 31, 2018 | 77.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
114.06M
Minimum
Jun 2020
912.24M
Maximum
Mar 2024
366.52M
Average
273.34M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 749.48M |
| Zoetis Inc | 14.16B |
| Annovis Bio Inc | 5.046M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.98M |
| Shareholders Equity (Quarterly) | 798.07M |